(72 days)
Not Found
No
The 510(k) summary describes a passive optical fiber for transmitting CO2 laser energy. There is no mention of any computational or analytical functions that would involve AI or ML. The device description focuses on the physical components and their material properties.
Yes.
The device incises, ablates, vaporizes, and coagulates soft tissues, indicating it is used for therapeutic purposes.
No
The device is described as a laser surgical instrument indicated for incision, ablation, vaporization, and coagulation of soft tissues, which are therapeutic actions, not diagnostic ones.
No
The device description clearly outlines a physical medical device, specifically an optical fiber assembly used for transmitting laser energy. It details material composition, dimensions, and functional characteristics related to hardware.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The intended use clearly states the device is for the "incision, ablation, vaporization and coagulation of body soft tissues". This describes a surgical tool used directly on living tissue within the body.
- Device Description: The description details a laser surgical instrument that transmits laser energy to a surgical site. This is consistent with a surgical device, not a device used to examine samples outside the body.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue samples, etc.) or providing diagnostic information based on such analysis. IVDs are typically used to diagnose diseases or conditions by testing samples in vitro (outside the body).
The device is a surgical instrument used for therapeutic purposes (cutting, ablating, etc.) on living tissue, which falls under the category of a medical device, but not specifically an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The OmniGuide Beam Path OTO-U Fiber for CO2 Laser Systems is indicated for the incision, ablation, vaporization and coagulation of body soft tissues including intra-oral tissue. It is indicated in the medical specialties of general and plastic surgery, oral/maxillofacial surgery, dentistry , dermatology, gynecology, gastroenterology, neurosurgery, urology and pulmonology, and can be used in open surgical procedures as well as endoscopic minimally invasive procedures in conjunction with rigid or flexible endoscopes, such as in laryngology, gastroscopy, colonoscopy, laproscopy, thoracoscopy, hysteroscopy and bronchoscopy.
The indications for use for which the delivery system is used for are dependent upon the cleared indications for use of the laser system and those laser system accessories to which it is attached.
Product codes
GEX
Device Description
The OmniGuide Beam Path OTO-U Fiber is a single use laser surgical instrument provided sterile for use in transmitting laser energy at 10.6 µm from a CO2 Laser System to a surgical site through an endoscope, flexible or rigid or using an accessory handpiece. It is connected to the laser system utilizing a standard ST II stainless steel fitting which is used by many laser manufacturers. The fiber has the following dimensions and composition:
Component: ST II Laser Connector, Dimensions: 17 mm L, Material: Stainless Steel, Body Contact: No
Component: Connector Insert (Ferrule), Dimensions: 128μm, Material: Die Cast Stainless Steel, Body Contact: No
Component: RFID Wing, Dimensions: 1.18" W x 0.510"H x 0.512"D, Material: Hytrel 6356, Body Contact: No
Component: SMA Medical Boot, Dimensions: 3.0 mm OD, Material: USP Class IV Plastic, Body Contact: No
Component: Fused Silica Core, Dimensions: 600 ± 15μm OD, Material: Silica, Body Contact: Yes
Component: Silver Coated Bore, Dimensions: 315 ± 10μm ID, Material: Silver, Body Contact: Yes
Component: Hard Clad Buffer, Dimensions: 630 ± 15μm OD, Material: Fluorinated Acrylate, Body Contact: Yes
Component: Tefzel Jacket, Dimensions: 1350 ± 70μm OD, Material: Tefzel, Body Contact: Yes
The device consists of an optical fiber assembly. The main functional characteristic is a Silver coating reflector that reflects and thereby contains and guides CO2 laser energy within the fiber. Silver coating is applied along the ID of the cladded fused silica core, allowing 10.6 µm laser energy to be guided along the fiber length and onto a surgical location. The fused silica core is cladded with a thin layer of Fluorinated Acrylate. The core is sheathed with a Tefzel polymer layer.
Helium gas is flowed in the core to provide cooling of the fiber as needed and to prevent contamination of the fiber core.
The fiber assembly is 1 to 2 meters long and transmits at the CO2 laser emission of 10.6 µm. The fiber can be used in single pulse mode, repeat pulse mode and CW mode. Power output is limited to 10 Watts.
The recommended distance between fiber tip and tissue is 3 mm and the recommended gas flow is less than 1 liters per minute.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Body soft tissues including intra-oral tissue.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Clinical Performance Data: Clinical trials were not deemed necessary as the OTO-U is using similar technology, has the same indications for use and has the same intended use.
Non-Clinical Bench Testing:
Biocompatibility: Biocompatibility was performed on the OmniGuide Beam Path OTO-U Fiber per ISO 10993-1 and the FDA Guidance Document Use of the International Standard ISO 10993-1, "Biological evaluation of medical devices- Part 1: Evaluation and testing within a risk management process, 2020 for a External communicating device contacting tissue/bone for a limited time of less than 24 hours. All the components are included in the legally marketed predicate or commonly used in 510(k) cleared marketed devices. Accordingly, biological testing included, and all testing met the requirements of the standards, USP requirements and FDA Guidance: Biocompatibility Data is in VOL_020
- Hemocompatibility:
- ISO 10993-4 Biological Evaluation of Medical Device-Part 4 Selection of Tests for Interaction with Blood
- ASTM F756-08, Standard Practice for the Assessment of Hemolytic Properties of Materials, 2008
- Cytotoxicity:
- AAMI/ANSI/ISO 10993-5 Biological evaluation of medical devices-Part 5 Tests for invitro cytotoxicity
- Irritation/Intracutaneous:
- ISO 10993-10 Biological Evaluation of Medical Devices-Part 10: Tests for Irritation and Skin Sensitization
- Acute Systemic Toxicity:
- ISO 10993-11 Biological Evaluation of Medical Devices-Part 11: Tests for Systemic Toxicity
- Pyrogen Test
- USP Rabbit Pyrogen Study, Material Mediated
Sterilization Validation:
- ISO 11135:2014 Amd:2018 Sterilization of Health Care Products
- Testing met the requirements of the protocol and are available for review by FDA.
Functional Testing: Functional Testing was performed to ensure the device was equivalent to the predicate devices and that the modified device met the requirements of the design Control Policy. All testing met the predetermined specifications. Protocols and results are available for FDA inspection and review.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The FDA logo is composed of the Department of Health and Human Services logo on the left, and the FDA acronym in a blue box, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text. The logo is clean and professional, reflecting the FDA's role in regulating and overseeing food and drug safety in the United States.
January 14, 2021
OmniGuide, Inc. David Johnson Director, QA/RA 4 Maguire Road Lexington, Massachusetts 02421
Re: K203241
Trade/Device Name: OmniGuide BeamPath OTO-U Fiber Regulation Number: 21 CFR 878.4810 Regulation Name: Laser Surgical Instrument For Use In General And Plastic Surgery And In Dermatology Regulatory Class: Class II Product Code: GEX Dated: December 15, 2020 Received: December 16, 2020
Dear David Johnson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE(@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Purva U. Pandya -S
Purva Pandya Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K203241
Device Name
OmniGuide Beam Path OTO-U Fiber for CO2 Laser Systems
Indications for Use (Describe)
The OmniGuide Beam Path OTO-U Fiber for CO2 Laser Systems is indicated for the incision, ablation, vaporization and coagulation of body soft tissues including intra-oral tissue. It is indicated in the medical specialties of general and plastic surgery, oral/maxillofacial surgery, dentistry , dermatology, gynecology, gastroenterology, neurosurgery, urology and pulmonology, and can be used in open surgical procedures as well as endoscopic minimally invasive procedures in conjunction with rigid or flexible endoscopes, such as in laryngology, gastroscopy, colonoscopy, laproscopy, thoracoscopy, hysteroscopy and bronchoscopy.
The indications for use for which the delivery system is used for are dependent upon the cleared indications for use of the laser system and those laser system accessories to which it is attached.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
K203241
510(k) Summary
| Submitter Information | |
|---|---|
| Submitter Name: | OmniGuide, Inc. |
| Address: | 4 Maguire Road |
| Lexington, MA 02421 | |
| Telephone 617 551 8410 | |
| Registration Number: | 3005350457 |
| Date of Preparation: | 11/01/2020 |
| Subject Device | |
| Trade Name: | OmniGuide® Beam Path OTO-U Fiber |
| Device: | CO2 Laser Powered Surgical Instrument |
| Product Code: | GEX |
| Regulation Number: | 21 CFR § 878.4810 |
| Classification Name: | Laser Surgical Instrument for use in general and plastic surgery |
| and in dermatology | |
| Regulatory Class: | II |
| Predicate Device | |
| Trade Name: | OmniGuide Beam Path OTO-M, OTO-S |
| Classification Name: | Laser Surgical Instrument for use in general and plastic surgery |
| and in dermatology. | |
| Predicate Premarket Notification: | K093451, K073313 |
| Manufacturer: | OmniGuide, Inc. |
| These two devices have not been subject to a design related recall. | |
| Reference Device: | No reference devices were used in this submission |
| Purpose of Submission: | The purpose of the submission is to expand the product offering of |
| the OTO product line to include a more flexible modified fiber | |
| body, a silver optical reflective coating the internal dimension of | |
| the fused silica, and modify the glass configuration of the existing | |
| cleared and marketed OTO product offering. |
4
| Device Description: | The OmniGuide Beam Path OTO-U Fiber is a single use laser |
|---|---|
| surgical instrument provided sterile for use in transmitting laser | |
| energy at 10.6 µm from a CO2 Laser System to a surgical site | |
| through an endoscope, flexible or rigid or using an accessory | |
| handpiece. It is connected to the laser system utilizing a standard | |
| ST II stainless steel fitting which is used by many laser | |
| manufacturers. The fiber has the following dimensions and | |
| composition: |
| Component | Dimensions | Material | Body Contact |
|---|---|---|---|
| ST II Laser Connector | 17 mm L | Stainless Steel | No |
| Connector Insert | |||
| (Ferrule) | 128μm | Die Cast Stainless Steel | No |
| RFID Wing | 1.18" W x 0.510"H x | ||
| 0.512"D | Hytrel 6356 | No | |
| SMA Medical Boot | 3.0 mm OD | USP Class IV Plastic | No |
| Fused Silica Core | 600 ± 15μm OD | Silica | Yes |
| Silver Coated Bore | 315 ± 10μm ID | Silver | Yes |
| Hard Clad Buffer | 630 ± 15μm OD | Fluorinated Acrylate | Yes |
| Tefzel Jacket | 1350 ± 70μm OD | Tefzel | Yes |
| Table 1. List of Fiber Components, Dimensions and Materials | |||||
|---|---|---|---|---|---|
Indications for Use
The OmniGuide Beam Path OTO-U Fiber for CO2 Laser Systems is indicated for the incision, excision, ablation, vaporization and coagulation of body soft tissues including intra-oral tissue. It is indicated in the medical specialties of general and plastic surgery, oral/maxillofacial surgery, dentistry , dermatology, gynecology, otorhinolaryngology, gastroenterology, neurosurgery, urology and pulmonology, and can be used in open surgical procedures as well as endoscopic minimally invasive procedures in conjunction with rigid or flexible endoscopes, such as in laryngology, gastroscopy, colonoscopy, laparoscopy, thoracoscopy, hysteroscopy and bronchoscopy.
The indications for use for which the delivery system is used for are dependent upon the cleared indications for use of the laser system and those laser system accessories to which it is attached.
5
Summary of Technological Characteristics:
| The device consists of an optical fiber assembly. The main
functional characteristic is a Silver coating reflector that reflects
and thereby contains and guides CO2 laser energy within the fiber.
Silver coating is applied along the ID of the cladded fused silica
core, allowing 10.6 \u00b5m laser energy to be guided along the fiber
length and onto a surgical location. The fused silica core is
cladded with a thin layer of Fluorinated Acrylate. The core is
| sheathed with a Tefzel polymer layer. | |
|---|---|
| Helium gas is flowed in the core to provide cooling of the fiber as | |
| needed and to prevent contamination of the fiber core. | |
| The fiber assembly is 1 to 2 meters long and transmits at the CO2 | |
| laser emission of 10.6 \u00b5m. The fiber can be used in single pulse | |
| mode, repeat pulse mode and CW mode. Power output is limited to | |
| 10 Watts. | |
| The recommended distance between fiber tip and tissue is 3 mm | |
| and the recommended gas flow is less than 1 liters per minute. | |
| Clinical Performance Data: | Clinical trials were not deemed necessary as the OTO-U is using |
| similar technology, has the same indications for use and has the |
same intended use.
Performance Standards: No performance standards have been established under Section 514 of the Food, Drug and Cosmetic Act for these devices.
Non-Clinical Bench Testing:
Biocompatibility:
Biocompatibility was performed on the OmniGuide Beam Path OTO-U Fiber per ISO 10993-1 and the FDA Guidance Document Use of the International Standard ISO 10993-1, "Biological evaluation of medical devices- Part 1: Evaluation and testing within a risk management process, 2020 for a External communicating device contacting tissue/bone for a limited time of less than 24 hours. All the components are included in the legally marketed predicate or commonly used in 510(k) cleared marketed devices. Accordingly, biological testing included, and all testing met the requirements of the standards, USP requirements and FDA Guidance: Biocompatibility Data is in VOL_020
6
- Hemocompatibility: ●
- o ISO 10993-4 Biological Evaluation of Medical Device-Part 4 Selection of Tests for Interaction with Blood
- o ASTM F756-08, Standard Practice for the Assessment of Hemolytic Properties of Materials, 2008
- Cytotoxicity: ●
- o AAMI/ANSI/ISO 10993-5 Biological evaluation of medical devices-Part 5 Tests for invitro cytotoxicity
- Irritation/Intracutaneous: ●
- o ISO 10993-10 Biological Evaluation of Medical Devices-Part 10: Tests for Irritation and Skin Sensitization
- Acute Systemic Toxicity: ●
- o ISO 10993-11 Biological Evaluation of Medical Devices-Part 11: Tests for Systemic Toxicity
- Pyrogen Test ●
- 0 USP Rabbit Pyrogen Study, Material Mediated
Sterilization Validation:
- Sterilization Validation
- o ISO 11135:2014 Amd:2018 Sterilization of Health Care Products
- Testing met the requirements of the protocol and are o available for review by FDA.
Cyber Security and Wireless Information:
- The OmniGuide Beam Path OTO-U Hollow Laser Fiber is ● not an electrical device and contains no computer. It contains passive RFID for product identification and authentication. There is no cybersecurity and wireless concerns because RFID is passive very short range (10mm RFID range) device and is recognizable by OmniGuide laser systems when plugged into the laser systems.
Software:
- There is no software associated or contained in the predicate or revised product. Therefore, there is no software documentation contained herein.
7
Functional Testing:
Functional Testing was performed to ensure the device was equivalent to the predicate devices and that the modified device met the requirements of the design Control Policy. All testing met the predetermined specifications. The requirements are documented below. Protocols and results are available for FDA inspection and review.
Summary of Substantial Equivalence:
The modified device, OmniGuide Beam Path OTO-U Fiber is substantially equivalent to the predicate marketed devices K093451 OmniGuide Beam Path CO2 Mark III WaveGuide Fiber with Low profile/Low Loss Tip and K073313 OmniGuide Beam Path CO2 Mark III WaveGuide Fiber with Low Profile Tip in that it has the same indications for use, the same hollow internal lumen to propagate CO2 laser energy and allow flow of helium gas. The OTO-U fiber has a silver coated internal lumen while the K093451 OmniGuide Beam Path Mark III Waveguide utilizes a glass photonic bandgap reflective lining. Both reflective linings serve the same purpose to allow propagation of laser energy at 10.6um wavelength from a CO2 Laser System with comparable transmission characteristics and providing similar laser power and laser spot size to surgical location. The OTO-U has an outer jacket of Tefzel while the OmniGuide Beam Path Mark III has an outer jacket of polyamide, both fibers have the same outside and length dimensions. Both service the same patient population. Both fibers have the same RFID tag providing information regarding power settings and identification. Both fibers have the same fittings to allow connection to a cleared CO2 laser system.
It has been shown in this 510(k) submission that the differences between the OmniGuide Beam Path OTO-U and the predicate devices do not raise any questions regarding its safety and effectiveness as demonstrated in the biocompatibility testing, functional testing and validation testing, OmniGuide Beam Path OTO-U as designed and manufactured, is determined to be substantially equivalent to the referenced predicate
Predicate OmniGuide K093451 and K073313 are attached in Appendix 1 of K203241 for reference.